Posted on October 27, 2020 by Sitemaster
New data on this topic — from a Phase II/III clinical trial — have just been presented at the virtual annual meeting of the American Society for Radiation Oncology (ASTRO). Basically, the data from this study by Sahgal et al. indicated that 24 Gy (in two 12 Gy doses) of stereotactic body radiation therapy (SBRT) was more effective in the elimination of spinal pain in patients with metastatic cancer as compared to 20 Gy (in five 4 Gy doses) of conventional, external beam radiation therapy (EBRT).
… READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bone, EBRT, metastatic, pain, radiation, SBRT, spine | 3 Comments »
Posted on March 15, 2018 by Sitemaster
Two retrospective studies were published in the last week, and they had some similar findings, but some dissimilar things to say about which treatment is best for high-risk prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", BBT, brachy boost, EBRT, external beam, outcome, radiation, surgery | 8 Comments »
Posted on February 14, 2017 by Sitemaster
In August last year, Kishan et al. showed a preliminary analysis of oncological outcomes among patients diagnosed with Gleason score 9 and 10 and treated with brachy boost therapy (EBRT + BT), external beam radiation therapy alone (EBRT), or surgery (see this link). … READ MORE …
Filed under: Management, Treatment | Tagged: "high risk", boost, brachy, BT, EBRT, outcome | 8 Comments »
Posted on January 9, 2016 by Sitemaster
The EORTC trial 22991 was designed and implemented to compare external beam radiation therapy (EBRT) + short-term androgen deprivation therapy (ADT) to EBRT alone as first-line therapy in patients with intermediate- and high-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ADT, androgen, deprivation, EBRT, external beam, high, intermediate, radiation, risk | 5 Comments »
Posted on November 2, 2015 by Sitemaster
The ASCENDE-RT randomized clinical trial demonstrated that the combination of external beam radiation therapy with a brachytherapy boost (EBRT + BT) significantly reduced biochemical progression-free survival. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: boost, brachytherapy, BT, EBRT, external beam, high, intermediate, mortality, outcome, radiation, risk | 3 Comments »
Posted on May 26, 2015 by Sitemaster
New registry data from the Cleveland Clinic shows good oncological control with low dose rate brachytherapy (LDRBT) monotherapy, at least for low-risk and low intermediate-risk groups. This is the first time I’ve seen LDRBT monotherapy data for higher-risk groups. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, brachytherapy, deprivation, EBRT, external, LDR, low-dose-rate, monotherapy, radiation | 6 Comments »
Posted on April 3, 2012 by Sitemaster
Long-term data from the Radiaton Treatment Oncology Group (RTOG) 00-19 Phase II trial of external beam radiation therapy (EBRT) + low-dose-rate permanent implant brachytherapy (LDR-BT) has suggested that this type of radiation treatment is probably no more effective than either EBRT or LDR-BT alone … but does have a greater risk for long-term side effects. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: brachytherapy, EBRT, external beam, LDR-BT, outcome, radiotherapy, risk | 3 Comments »
Posted on February 28, 2012 by Sitemaster
Traditionally, men with prostate cancer who had recurrent disease after first-line surgery or first-line radiation therapy had a limited number of treatment options, but we are now seeing a significant expansion in the range of options available (although limited data are as yet available to support the effectiveness of nearly all these options). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: brachytherapy, cryotherapy, EBRT, HIFU, radiation, salvage, surgery | 5 Comments »
Posted on November 3, 2011 by Sitemaster
The big news today is the publication, in The Lancet, of the interim results of the NCIC CTG PR.3/MRC UK PR07 trial, originally presented by Warde et al. at the annual meeting of the American Society for Clinical Oncology in June 2010 and then by Mason et al. at the annual meeting of the American Society for Radiation Oncology (ASTRO) that September. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: "high risk", ADT, androgen deprivation therapy, EBRT, external beam radiation therapy, localized, locally advanced | Leave a comment »
Posted on September 17, 2011 by Sitemaster
Over the past 20 years there has been an explosion in the different ways that we use varied types of external beam radiation therapy for the treatment of localized and locally advanced forms of prostate cancer. Where is the newly diagnosed patient able to find a good, basic introduction? … READ MORE …
Filed under: Management, Treatment | Tagged: 3D-CRT, CyberKnife, EBRT, external beam radiation therapy, IGRT, IMRT, introduction, PBRT, SBRT, TomoTherapy | 2 Comments »
Posted on August 26, 2011 by Sitemaster
Academic research into the side effects of different treatments for localized prostate cancer have long been hampered by the lack of consistently used criteria for the assessment of those side effects at baseline and at defined time-periods post-treatment. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: EBRT, laparoscopic, radiation therapy, radical prostatectomy, RALP, robot-assisted, side effects, surgery | 3 Comments »
Posted on August 16, 2011 by Sitemaster
A second, small study has now offered additional data on clinical experience of the use of high-intensity focused ultrasound (HIFU) as a form of salvage therapy in men initially diagnosed with localized prostate cancer, but with a rising PSA after external beam radiation therapy (EBRT) as their first-line treatment. … READ MORE …
Filed under: Management, Treatment | Tagged: EBRT, external beam radiation, HIFU, high-intensity focused ultrasound, salvage | 12 Comments »
Posted on August 12, 2011 by Sitemaster
Men with locally recurrent prostate cancer after first-line external beam radiation therapy (EBRT) have historically had three options for second-line treatment: salvage radical prostatectomy, salvage cryoablation, and salvage brachytherapy. … READ MORE …
Filed under: Management, Treatment | Tagged: EBRT, external beam radiation therapy, HIFU, high-intensity focused ultrasound, QOL, quality of life, salvage | Leave a comment »
Posted on July 14, 2011 by Sitemaster
As we first reported in March 2010, when data were originally presented at the Genitourinary Cancers Symposium, RTOG 94-08 has shown that 4 months of androgen deprivation therapy (ADT) before and during external beam radiation therapy (EBRT) reduces the overall and the prostate cancer-specific mortality rates for men with localized prostate cancer (clinical stages T1b, T1c, T2a, or T2b). … READ MORE …
Filed under: Management, Treatment | Tagged: adjuvant, ADT, androgen deprivation, EBRT, mortality, neoadjuvant, outcome, radiation therapy, RTOG 94-08 | Leave a comment »
Posted on June 4, 2011 by Sitemaster
For men undergoing the combination of external beam radiation therapy (EBRT) and androgen deprivation therapy (ADT), for treatment of prostate cancer there is a significant risk for gastrointestinal (GI) toxicity over time. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: 3D-CRT, ADT, androgen deprivation, EBRT, gastrointestinal, IMRT, toxicity | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 